Australia markets closed

Anatara Lifesciences Ltd (ANR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.02200.0000 (0.00%)
At close: 04:10PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 3.69M
Enterprise value 2.40M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.31
Price/book (mrq)4.00
Enterprise value/revenue 2.27
Enterprise value/EBITDA -1.20

Trading information

Stock price history

Beta (5Y monthly) 0.61
52-week change 3-31.07%
S&P500 52-week change 328.30%
52-week high 30.0488
52-week low 30.0207
50-day moving average 30.0227
200-day moving average 30.0274

Share statistics

Avg vol (3-month) 354.51k
Avg vol (10-day) 328.68k
Shares outstanding 5167.89M
Implied shares outstanding 6167.89M
Float 881.58M
% held by insiders 143.51%
% held by institutions 110.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin -162.40%
Operating margin (ttm)274.88%

Management effectiveness

Return on assets (ttm)-80.21%
Return on equity (ttm)-176.79%

Income statement

Revenue (ttm)1.25M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -2.02M
Net income avi to common (ttm)-2.02M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)401.18k
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.87
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-2.26M
Levered free cash flow (ttm)-1.53M